Resveratrol treatment of cultured human colon cancer cells increased the expression of miR-663, which decreased the levels of its target proteins, program cell death protein4 (PDCD4), phosphatase and tensin homolog (PTEN) and transforming growth factor (TGF; Tili et al., 2010). The gene discussed is PTEN; the disease is malignant colon neoplasm.